These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18392472)
1. [Which is the importance of the budgetary analysis of projects in clinical research?]. Bueno M; Nunes DB; Dainesi SM Rev Assoc Med Bras (1992); 2008; 54(1):5-6. PubMed ID: 18392472 [No Abstract] [Full Text] [Related]
2. Has Big Pharma hijacked the European health research budget? Galsworthy MJ; Palumbo L; McKee M Lancet; 2014 Apr; 383(9924):1210. PubMed ID: 24656537 [No Abstract] [Full Text] [Related]
3. The NIH budget and the future of biomedical research. Loscalzo J N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006 [No Abstract] [Full Text] [Related]
5. Getting it right: industry sponsorship and medical research. Baird P CMAJ; 2003 May; 168(10):1267-9. PubMed ID: 12743071 [No Abstract] [Full Text] [Related]
6. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry. Winther FO; Hole OP; Nitter-Hauge S Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994 [TBL] [Abstract][Full Text] [Related]
8. Biomedical research in an age of austerity. Moses H; Dorsey ER JAMA; 2012 Dec; 308(22):2341-2. PubMed ID: 23240142 [No Abstract] [Full Text] [Related]
9. [Commercialization of the medical research is a reality. What is the limit?]. Naeser K Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105 [No Abstract] [Full Text] [Related]
10. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
11. Medicine in the Noise Age: what can we believe? Angell M Account Res; 2001; 8(3):189-95. PubMed ID: 12481786 [No Abstract] [Full Text] [Related]
12. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
13. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review. Tereskerz PM Account Res; 2003; 10(3):137-58. PubMed ID: 14979317 [No Abstract] [Full Text] [Related]
14. Safeguarding innovation through an economic downturn. Barker R Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):347-9. PubMed ID: 20715908 [No Abstract] [Full Text] [Related]
15. In tight times, companies fill the funding gap. Savage N Cell; 2015 May; 161(4):699-701. PubMed ID: 25957675 [TBL] [Abstract][Full Text] [Related]
17. Medicine and the pharmaceutical industry. Baxter P Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771 [No Abstract] [Full Text] [Related]
18. Budgeting, funding, and managing clinical research projects. Hatfield E; Dicks E; Parfrey P Methods Mol Biol; 2009; 473():299-311. PubMed ID: 19160746 [TBL] [Abstract][Full Text] [Related]
19. Cultivating and investing in clinical research in China. Zhang J; Huang H; Shen X Lancet; 2015 Oct; 386(10002):1506-8. PubMed ID: 26466054 [No Abstract] [Full Text] [Related]
20. US doctors earn speaking and consulting fees from drug companies that sponsor their research. McCarthy M BMJ; 2014 Mar; 348():g2410. PubMed ID: 24677695 [No Abstract] [Full Text] [Related] [Next] [New Search]